Who founded Septerna?

Septerna was founded by Robert Lefkowitz, Arthur Christopoulos, Patrick Sexton in 2019.

Who are Septerna's investors?

Septerna's investors include Catalio Capital Management, LP, RA Capital, Samsara BioCapital, Vertex Ventures HC, Third Rock Ventures.

How much funding has Septerna raised?

Septerna has disclosed $73.5M raised across 1 round.

Where is Septerna headquartered?

Septerna is headquartered in South San Francisco, US.

Septerna

South San Francisco, US · Founded 2019 · 5 known investors

Septerna is a biotechnology company that uses its proprietary Native Complex Platform to discover and develop oral small molecule therapies targeting GPCRs for endocrinology, immunology and inflammation, and metabolic diseases.

AI & Machine Learning Biotech Deep Tech

Founders & leadership

Septerna was founded in 2019 by Robert Lefkowitz, Arthur Christopoulos, and Patrick Sexton.

Robert LefkowitzFounder

Arthur ChristopoulosFounder

Patrick SextonFounder

Ran XiaoinVP, Finance and Business Operations

Elizabeth BhattExecutive

Samira ShaikhlyinChief People Officer

Board

Alan EzekowitzBoard director

Jeffrey TongBoard director

Jake SimsonBoard director

Abraham BassanBoard director

Jeffrey FinerChief Executive Officer and Co-Founder

Investors · 5

Catalio Capital Management, LPNew York

RA CapitalBostonvia Jake Simson · board

Samsara BioCapitalPalo Alto

Vertex Ventures HCSingapore · $500K – $10M

Third Rock VenturesreportedBoston · $100K – $5Mvia Jeffrey Tong · board

Reported raises · per SEC filings

Form D private placements

$73.5M disclosed across 1 round · 2023

▶$73.5MraisedJul 2023 · 30 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Alan EzekowitzDirector
Ran XiaoExecutive Officer
Elizabeth BhattExecutive Officer
Jeffrey TongDirector
Jake SimsonDirector
Abraham BassanDirector
Jeffrey FinerExecutive Officer, Director
Samira ShaikhlyExecutive Officer

Offering amount: $150M
Amount sold: $73.5M
First sale: Jun 2023
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Septerna do?: Septerna is a biotechnology company that uses its proprietary Native Complex Platform to discover and develop oral small molecule therapies targeting GPCRs for endocrinology, immunology and inflammation, and metabolic diseases.
Who founded Septerna?: Septerna was founded by Robert Lefkowitz, Arthur Christopoulos, Patrick Sexton in 2019.
Who are Septerna's investors?: Septerna's investors include Catalio Capital Management, LP, RA Capital, Samsara BioCapital, Vertex Ventures HC, Third Rock Ventures.
How much funding has Septerna raised?: Septerna has disclosed $73.5M raised across 1 round.
Where is Septerna headquartered?: Septerna is headquartered in South San Francisco, US.